In support of the idea that CD84 expression confers strong survival advantages to AML cells, we observed that mice xenografted with CD84-overexpressing cells had substantially lower survival compared with control animals, an effect that was completely reverted by CD84 knockdown in the same experimental setting. This evidence concerns the gene CD84 and acute myeloid leukemia.